Preclinical dose response study shows NR2E3 can attenuate retinal degeneration in the retinitis pigmentosa mouse model RhoP23H+/−Shannon M. McNamee, Neena B. Haider, Maiya Whalen et al.|Gene Therapy|2024Cited by 10
Evaluating therapeutic potential of NR2E3 doses in the rd7 mouse model of retinal degenerationShannon M. McNamee, Neena B. Haider, Monica Akula et al.|Scientific Reports|2024Cited by 3